Saudi venture capital firm RVC participated in $21 million investment in UK firm

Saudi Venture Capital firm Riyadh Valley Company (RVC) and a consortium invested $21 million in UK biotechnology company Prokarium

Prokarium is headquartered in London and is a clinical-stage biopharmaceutical company focused on developing microbial cancer immunotherapies. Riyadh Valley Company (RVC) is the investment arm of King Saud University in Riyadh, Saudi Arabia. It has invested in several firms including GLM Company, Calltech Co, SOLEXEL, Advanced Dental Technologies, Aser Technologies and Knowledge Developers. Khalid Al-Saleh is the director appointed by RVC at Prokarium.

Riyadh Valley Company (RVC) is listed in the Middle East Investors Directory with the code SIJ54.